Literature DB >> 16879297

Idiopathic inflammatory demyelinating disorders after acute transverse myelitis.

K H Chan1, K L Tsang, G C Y Fong, S L Ho, R T F Cheung, W Mak.   

Abstract

Acute transverse myelitis (ATM) is commonly para-infectious. Recurrent ATM occurs in connective tissue diseases (CTD), infective myelitis and idiopathic inflammatory demyelinating disorders (IIDD) including multiple sclerosis (MS) and neuromyelitis optica (NMO). Previous studies might include NMO and idiopathic recurrent transverse myelitis (IRTM) as MS. The aim was to study the outcome of patients after a first attack of idiopathic ATM. Idiopathic ATM patients over a 6-year period were retrospectively studied. Known causes of myelopathy were excluded. Among 32 patients studied, 20 (63%) had single ATM attack upon follow up for 39-93 months, three developed recurrent ATM related to CTD (two systemic lupus erythematosus and one anti-Ro antibody positive) and nine (28.1%) developed recurrent neuroinflammation compatible with IIDD. Among IIDD patients, three had NMO, two restricted variant of NMO, three IRTM and one classical MS. NMO, its variant and IRTM had mean spinal MRI abnormality of 3.7, 2.1 and 3.9 vertebral segments respectively while non-recurrent ATM had 1.6 vertebral segments. Four (80%) of the five patients with NMO or its variant had poor neurological prognosis versus only one (5%) of non-recurrent ATM patients. IRTM patients had advanced mean onset age, 62 years vs. 43 years for non-recurrent ATM patients. In IIDD patients presenting with ATM as first attack of neuroinflammation, NMO and its variant (56%) were most frequent, then IRTM (33%), with classical MS (11%) the rarest. As long-term treatments for NMO are different from MS, early recognition of NMO and its variant is important for prevention of serious neurological deficits.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16879297     DOI: 10.1111/j.1468-1331.2006.01376.x

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


  7 in total

Review 1.  A differential diagnosis of central nervous system demyelination: beyond multiple sclerosis.

Authors:  Christopher Eckstein; Shiv Saidha; Michael Levy
Journal:  J Neurol       Date:  2011-09-20       Impact factor: 4.849

2.  [Revision of McDonald's new diagnostic criteria for multiple sclerosis].

Authors:  H Wiendl; B C Kieseier; R Gold; R Hohlfeld; M Bendszus; H-P Hartung
Journal:  Nervenarzt       Date:  2006-10       Impact factor: 1.214

3.  Acute transverse myelitis in demyelinating diseases among the Chinese.

Authors:  R Li; W Qiu; Z Lu; Y Dai; A Wu; Y Long; Y Wang; J Bao; X Hu
Journal:  J Neurol       Date:  2011-05-18       Impact factor: 4.849

4.  The clinical course of idiopathic acute transverse myelitis in patients from Rio de Janeiro.

Authors:  Marina Papais Alvarenga; Luiz Claudio Santos Thuler; Silvio Peçanha Neto; Claudia Cristina Ferreira Vasconcelos; Solange Gomes Camargo; Marcos Papais Alvarenga; Regina Maria Papais-Alvarenga
Journal:  J Neurol       Date:  2010-02-03       Impact factor: 4.849

Review 5.  Magnetic resonance imaging in neuromyelitis optica spectrum disorder.

Authors:  Laura Clarke; Simon Arnett; Kate Lilley; Jacky Liao; Sandeep Bhuta; Simon A Broadley
Journal:  Clin Exp Immunol       Date:  2021-07-06       Impact factor: 4.330

6.  Assessment of Clinical Outcomes in Patients Presenting with Transverse Myelitis: A Tertiary Care Experience from a Developing Country.

Authors:  Aijaz Ali; Syeda Beenish Bareeqa; Amir Riaz; Syed Ijlal Ahmed; Muhammad Hassan Shaikh; Muhammad Ishaq Ghauri
Journal:  Cureus       Date:  2019-03-29

7.  Para-infectious anti-GD2/GD3 IgM myelitis during the Covid-19 pandemic: Case report and literature review.

Authors:  Luis Alberto Rodríguez de Antonio; Inés González-Suárez; Inés Fernández-Barriuso; María Rabasa Pérez
Journal:  Mult Scler Relat Disord       Date:  2021-01-21       Impact factor: 4.339

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.